News_Hope Pharmaceutical_Focused on drug research and development

News & Events

——

Expanding Global Reach | HOPE Wraps Up CPHI Worldwide 2026 on a High Note! 🌏

Every face-to-face conversation in Milan has laid a stronger foundation of mutual trust. We extend our heartfelt thanks to all the clients, partners, and colleagues who visited our booth. Milan is not the finish line, but the starting point for lasting collaborations.

Click to see more →

2026-08

BIC China 2026 | Sharing Insights on New Industry Trends

From August 20 to 21, 2026, the 5th BIC China Biopharmaceutical Industry Chain Development Conference was held in Hangzhou. Hosted by the Zhejiang Pharmaceutical Industry Association and the Zhejiang Provincial Drug MAH Transformation Platform, and organized by the Hangzhou (Innovation) Institute of Medicine of China Pharmaceutical University and the Qiantang MAH Institute, the conference drew more than 1,500 delegates from regulatory authorities, research institutes, pharmaceutical companies and industry service organizations, with over 1,000 companies represented. HOPE sent a team to take part in the full two-day program and received visiting clients and partners at Booth A24.

2026-08

Invitation | HOPE Invites You to CPHI Milan 2026

CPHI Milan 2026, the world's premier pharmaceutical trade show, will be held from October 6–8, 2026 at Fiera Milano in Milan, Italy. We cordially invite all clients, partners, and industry peers to visit our booth for discussions, insights into industry trends, and exploration of new opportunities for collaboration.

2026-08

Announcement | Invention Patent Granted

On August 11, 2026, HOPE achieved a significant breakthrough in its independently developed compound synthesis technology, with the related invention patent officially granted by the China National Intellectual Property Administration. This marks another strong demonstration of the company's commitment to independent innovation and continuous strengthening of its intellectual property defenses, signifying a solid step forward on the path toward self-reliance in key active pharmaceutical intermediate production.

2026-07

CPIC 2026: A Resounding Success‌

On July 22, 2026, the first China Pharmaceutical Innovation Conference (CPIC 2026), hosted by Tonacea, grandly opened at the Shanghai National Exhibition and Convention Center.

2024-12

[Exciting News] Haibu Pharmaceutical's Ibrutinib Capsules have received the second domestic drug registration approval.

Recently, the ibrutinib capsules (140mg) independently developed by Haibu Pharmaceutical have obtained the production approval, making it the second company in China to receive approval for this product after Xiansheng Pharmaceutical.

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.